Nautilus Biotechnology, Inc.
NAUT· Nasdaq
NAUTNautilus Biotechnology, Inc.
Filed Oct 31, 2023 · 10-Q · 31 days after period end · 0001808805-23-000075
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$15.88M | -$14.06M | -$14.50M | -$3.98M |
| EPS Diluted | -$0.13 | -$0.11 | -$0.12 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nautilus Biotechnology, Inc. · CIK 1808805 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Oct 31, 2023 · 31 d after period end
